Table 3.

Clinical characteristics of the patients with intracranial aneurysms that increased in size during follow-up

CharacteristicPatient No.
40106106155162165242582
Age at first MRA, yr4829294545596147
SexWMMMWWMW
LocationR ICAR MCAL MCAACoABAR ICAR PAR MCA
Size at first MRA, mm23255442
Duration of follow-up, mo1072592599826620760173
Number of MRAs699317547
Size at last MRA, mm34566565
Increase in size, mm11311133
GenotypePKD1PKD1PKD1NAPKD1NANANA
Family history of UIA/SAHSAHUIAUIANoSAHNoSAHNo
HypertensionYesYesYesYesYesYesYesYes
DyslipidemiaNoNoNoNoNoYesYesYes
History of smokingNoNoNoYesNoNoYesYes
eGFR at first MRA, ml/min per 1.73 m24860603457445935
eGFR at last follow-up, ml/min per 1.73 m2TXTXTX13TX1557TX
DeathNoNoNoNoNoNoYesNo
  • MRA, magnetic resonance angiography; W, women; M, men; R, right; ICA, internal carotid artery; MCA, middle cerebral artery; L, left; ACoA, anterior communicating artery; BA, basilar artery; PA, pericallosal artery; NA, not available; UIA, unruptured intracranial aneurysm; SAH, subarachnoid hemorrhage; TX, kidney transplant.